| Biogen Idec, Inc. - SWOT Analysis company profile is | | | | -Data is supplemented with details on Biogen Idec, |
| the essential source for top-level company data and | | | | Inc. history, key executives, business description, |
| information. Biogen Idec, Inc. - SWOT Analysis | | | | locations and subsidiaries as well as a list of products |
| examines the company's key business structure and | | | | and services and the latest available statement from |
| operations, history and products, and provides | | | | Biogen Idec, Inc. |
| summary analysis of its key revenue lines and | | | | Reasons to Purchase |
| strategy. | | | | - Support sales activities by understanding your |
| Biogen Idec is a biopharmaceutical company engaged | | | | customers' businesses better |
| in the process of discovering, developing, | | | | - Qualify prospective partners and suppliers |
| manufacturing, and commercializing the therapies in | | | | - Keep fully up to date on your competitors' business |
| the areas of oncology, neurology and immunology. | | | | structure, strategy and prospects |
| The company's key products include TYSABRI | | | | - Obtain the most up to date company information |
| (natalizumab), AVONEX (Interferon beta-1a), and | | | | available" |
| RITUXAN (rituximab). The company primarily | | | | Table of Contents : |
| operates in the US and Europe. It is headquartered in | | | | This product typically includes the following sections: |
| Cambridge, Massachusetts and employed 4,700 | | | | SWOT COMPANY PROFILE: Biogen Idec, Inc. |
| people as of December 2008. The company recorded | | | | Key Facts: Biogen Idec, Inc. |
| revenues of $4,097.5 million during the financial year | | | | Company Overview: Biogen Idec, Inc. |
| (FY) ended December 2008, an increase of 29.2% | | | | Business Description: Biogen Idec, Inc. |
| over FY2007. The increase was due to higher sales | | | | Company History: Biogen Idec, Inc. |
| of TYSABRI, RITUXAN and AVONEX. The operating | | | | Key Employees: Biogen Idec, Inc. |
| profit of the company was $1,213.6 million during | | | | Key Employee Biographies: Biogen Idec, Inc. |
| FY2008, an increase of 55.6% over FY2007. The net | | | | Products & Services Listing: Biogen Idec, Inc. |
| profit was $783.2 million in FY2008, an increase of | | | | Products & Services Analysis: Biogen Idec, Inc. |
| 22.7% over FY2007. | | | | SWOT analysis: Biogen Idec, Inc. |
| Scope of the Report | | | | *Strengths: Biogen Idec, Inc. |
| - Provides all the crucial information on Biogen Idec, | | | | *Weaknesses: Biogen Idec, Inc. |
| Inc. required for business and competitor intelligence | | | | *Opportunities: Biogen Idec, Inc. |
| needs | | | | *Threats: Biogen Idec, Inc. |
| - Contains a study of the major internal and external | | | | Company View: Biogen Idec, Inc. |
| factors affecting Biogen Idec, Inc. in the form of a | | | | Top Competitors: Biogen Idec, Inc. |
| SWOT analysis as well as a breakdown and | | | | Location and Subsidiary: Biogen Idec, Inc. |
| examination of leading product revenue streams of | | | | *Head Office: Biogen Idec, Inc. |
| Biogen Idec, Inc. | | | | *Other Locations and Subsidiaries: Biogen Idec, Inc. |